Lytic Bacteriophage Is a Promising Adjunct to Common Antibiotics across Cystic Fibrosis Clinical Strains and Culture Models of <i>Pseudomonas aeruginosa</i> Infection.

Martin, Isaac; Morales, Sandra; Alton, Eric W F W; Davies, Jane C

Lytic Bacteriophage Is a Promising Adjunct to Common Antibiotics across Cystic Fibrosis Clinical Strains and Culture Models of Pseudomonas aeruginosa Infection.

Martin, Isaac; Morales, Sandra; Alton, Eric W F W; Davies, Jane C.

Afiliação

Martin I; National Heart and Lung Institute, Imperial College London, Emmanuel Kaye Building, London SW3 6LY, UK.
Morales S; Royal Brompton Hospital, Part of Guy's and St. Thomas' Trust, Sydney St., London SW3 6NP, UK.
Alton EWFW; Department of Paediatrics and Translational Medicine, The Hospital for Sick Children, University of Toronto, Toronto, ON M5G 1X8, Canada.
Davies JC; AmpliPhi Biosciences, Brookvale, NSW 2100, Australia.

Antibiotics (Basel) ; 12(3)2023 Mar 16.

Article em En | MEDLINE | ID: mdl-36978460

Palavras-chave

Pseudomonas aeruginosa; adjunctive therapy; antimicrobial resistance; bacteriophage; cystic fibrosis; novel antimicrobials; pulmonary infection

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article